Paperpal Prime Logo

EJNMMI Research : Impact Factor & More

eISSN: 2191-219XpISSN: 2191-219X
JournalOpen Access

Aims and Scope of EJNMMI Research

EJNMMI Research publishes new basic, translational and clinical research in the field of nuclear medicine and molecular imaging. Regular features include original research articles, rapid communication of preliminary data on innovative research, interesting case reports, editorials, and letters to the editor. Educational articles on basic sciences, fundamental aspects and controversy related to pre-clinical and clinical research or ethical aspects of research are also welcome. Timely reviews provide updates on current applications, issues in imaging research and translational aspects of nuclear medicine and molecular imaging technologies.The main emphasis is placed on the development of targeted imaging with radiopharmaceuticals within the broader context of molecular probes to enhance understanding and characterisation of the complex biological processes underlying disease and to develop, test and guide new treatment modalities, including radionuclide therapy. Less

Key Metrics

CiteScore
4.6
Impact Factor
< 5
SJR
Q2Radiology, Nuclear Medicine and Imaging
SNIP
0.96
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on EJNMMI Research

EJNMMI Research Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher SPRINGER
Language English
Frequency Continuous publication
Article Processing ChargesEUR 2390 | USD 2890 | GBP 1990
Publication Time13
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorEuropean Association of Nuclear Medicine (EANM)
FrequencyContinuous publication
Publication Start Year2011
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 13
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in EJNMMI Research ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in EJNMMI Research

[161Tb]Tb-DOTATATE as a potential treatment option for neuroblastoma
  • 28 Jul 2026
  • EJNMMI Research
Early detection and localization of recurrent prostate cancer using ^{18}F-DCFPyL\xa0PET/CT in patients with low and ultra-low PSA levels
  • 27 Jul 2026
  • EJNMMI Research
Preclinical PET characterization of [68Ga]Ga-EMP-100 for non-invasive assessment of c-Met in NSCLC.
  • 22 Jul 2026
  • EJNMMI research
Head-to-head comparison of 99mTc-MIP-1404 CZT SPECT/CT and 68Ga/PSMA-11 PET/CT for primary staging of high-risk prostate cancer: a phase II study
  • 22 Jul 2026
  • EJNMMI Research
Optimization of imaging parameters for Yttrium-90 bremsstrahlung emission computed tomography after selective internal radiotherapy.
  • 19 Jul 2026
  • EJNMMI research
Preclinical evaluation of [18F]fluoroethylresorufin as PET tracer for cerebral amyloid angiopathy
  • 16 Jul 2026
  • EJNMMI Research
[161Tb]Tb-DOTATATE as a potential treatment option for neuroblastoma
  • 28 Jul 2026
  • EJNMMI Research
Early detection and localization of recurrent prostate cancer using ^{18}F-DCFPyL\xa0PET/CT in patients with low and ultra-low PSA levels
  • 27 Jul 2026
  • EJNMMI Research
Preclinical PET characterization of [68Ga]Ga-EMP-100 for non-invasive assessment of c-Met in NSCLC.
  • 22 Jul 2026
  • EJNMMI research
Head-to-head comparison of 99mTc-MIP-1404 CZT SPECT/CT and 68Ga/PSMA-11 PET/CT for primary staging of high-risk prostate cancer: a phase II study
  • 22 Jul 2026
  • EJNMMI Research
Optimization of imaging parameters for Yttrium-90 bremsstrahlung emission computed tomography after selective internal radiotherapy.
  • 19 Jul 2026
  • EJNMMI research
Preclinical evaluation of [18F]fluoroethylresorufin as PET tracer for cerebral amyloid angiopathy
  • 16 Jul 2026
  • EJNMMI Research

FAQs on EJNMMI Research